Digital therapeutics and healthcare innovation
Digital technology is transforming the way that healthcare is practiced and delivered, with areas like digital therapeutics forging ahead to complement traditional medical approaches and augment patient care.
The development of software applications that are available with a prescription took a major step forward last year with the first FDA approval for a mobile medical application with both a safety and efficacy label.
From doctor-patient communication to managing healthcare costs, from healthcare monitoring to clinician workflow, the range of digital health tools and services available is rapidly expanding.
We’ll be looking at how digital and traditional approaches to medicine are being combined to improve patient outcomes.
This free pharmaphorum webinar saw our expert panel discuss:
- Growth and investment in digital health, the digital therapeutics (DTx) spectrum and where pharma is active in this space
- What is a DTx, how the digital health landscape is expanding and what are the benefits of DTx
- The value of DTx for patients, with some case studies for patients and HCPs (and pharma) and a look at the reimbursement of DTx – what to address and what counts as ‘value’
- The anatomy of a DTx, the customer experience component, and then a look at the ‘go-to-market’ part of these solutions
The live webinar took place on Friday 12 October at 15.00 BST/16.00 CEST. To view the event please click here or on the button above or below.
Roberto Ascione, CEO, Healthware International
Trained as a medical doctor and in marketing communications, Roberto’s passion for medicine, computer science and human-technology interactions have led to his lifelong commitment and dedication to the advancement and spreading of digital healthcare. He holds a strong belief that digital innovations and technology will be the most impactful drivers of change in healthcare. Roberto is currently CEO at Healthware International, the largest, independent, healthcare consultancy (more than 700 people in Europe and USA through the Intouch Solutions joint venture) helping life sciences companies, healthcare stakeholders and start-ups navigate the transformation in healthcare, from strategy to technology.
Roberto is also very active in the digital health ecosystem in various advisor capacities both in Europe and the US to companies, start-ups and investors; among others he has been recognised Best Industry Leader by The Health 2.0 – 10 Year Global Retrospective Awards in 2016, nominated Transformational Leader at the 2017 PM360 ELITE Awards and named among the 100 Most Inspiring People by PharmaVOICE in 2017.
He is a regular keynoter at numerous conferences, has been President of the HealthTech Summit , and is Founding Advisor of the Digital Therapeutics Alliance as well as Chairman at Frontiers Health, which emerged as one of the leading digital health conferences globally.
In the past 20 years Roberto has been focusing on marketing and communications, business transformation and innovation in health and wellness: between 1997 and 2006 he founded multiple companies at the intersection of healthcare and technology with main exit to Publicis Groupe in 2007; held multiple roles at Publicis Healthcare up to 2013 as global president at Razorfish Healthware leading a team of more than 300 in nine countries.
Megan Coder, Executive Director, Digital Therapeutics Alliance
Megan Coder, PharmD, MBA, is executive director of the Digital Therapeutics Alliance, whose mission is to broaden the understanding, adoption, and integration of clinically-validated digital therapeutic solutions into mainstream healthcare through education, advocacy, and research. With more than a decade of experience in the healthcare industry, Megan’s expertise extends from strategic growth and partnership development within the digital health sector, to the direct delivery of patient care. Prior to joining the DTA, Megan worked with Voluntis, Iodine, the Pharmaceutical Care Management Association and the Pharmacy Technician Certification Board.
A proud Badger, Megan graduated from the University of Wisconsin—Madison School of Pharmacy and completed an executive residency in association management and leadership with the American Pharmacists Association.
Pierre Leurent, CEO and Founder, Voluntis
Pierre Leurent, CEO and founder of Voluntis, has 20 years of experience in digital health in the United States and Europe.
Voluntis’ mission is to improve the real-world value of therapies by providing patients and clinicians with digital therapeutics. Its clinical-grade regulatory-cleared mobile and cloud solutions embed advanced real-time decision support algorithms to enable patients to better manage their treatment in remote collaboration with their healthcare team. Prior to starting Voluntis in 2001, Pierre worked at GE Medical Systems, where he took part in the development of medical imaging software. He also held several positions at HealthCenter Internet Services, a San Francisco-based vendor of electronic medical record solutions.
Pierre is a founding member of the Digital Therapeutics Alliance, of which he serves as the first chairman. He also chairs the eHealth France Alliance whose members are leading trade organisations representing digital and life sciences companies in France. He is a graduate of the Ecole Centrale Paris engineering school.
Marc Sluijs, Founder, DigitalHealth.Network
Marc is focused on scaling the digital health sector through his involvement in growth investment, M&A, and large industry partnerships. He has been advising on digital health strategy and investment through his company Digitalhealth.Network since early 2015, and has been active in digital health since 2010. Marc is passionate about fostering the global digital health ecosystem, with a particular focus on bringing together investors and entrepreneurs as well as innovators from the Life Sciences industry, with the aim of driving scale and adoption of digital health solutions. Since 2015, Marc has been an advisor to Merck Global Health Innovation Fund, the largest dedicated global digital health venture fund. In addition, he acts as advisor on digital health strategy and partnerships to Nestlé, works with Private Equity investors on digital health portfolio acquisitions, and helps selected growth stage companies connect with potential acquirers.
Marc is part of the Steering Committee for Frontiers Health, and has chaired the HealthTech Summit, having developed this in just 2 years into the leading European event for investors in digital health. Over the years he has built up a unique personal network of 1000+ digital health stakeholders, including leading PE/VC investors representing >$1400bn, founders/CEO’s of digital health companies and Life Sciences industry innovators. For more than 6 years now, Marc’s monthly digital health newsletter has been recognised as one of the most comprehensive sources of market information by many of the 1000+ readers. Marc regularly participates as a speaker and jury member in pan-European events focused on digital health investment.
Marc has 20+ years of experience working with the Life Sciences and Technology industry, in health information (IQVIA/IMS Health), Life Sciences management consulting (Accenture), and biotech (Merck-Serono). Most recently, Marc was responsible for M&A and digital health partnerships at Oracle Health Sciences, where his involvement ranged from the acquisition of ClearTrial and partnership with Greenphire to Oracle’s investment in Proteus Digital Health.
Dominic Tyer, Creative Director, pharmaphorum (moderator)
Dominic Tyer is a trained journalist and editor with 19 years of pharmaceutical and healthcare publishing experience. He serves as a contributing editor at pharmaphorum media, which facilitates productive engagement for pharma, bringing healthcare together to drive medical innovation. He is also creative director at the company’s specialist healthcare content consultancy, pharmaphorum connect.
* When you click to register for this webinar you will be taken to a website run by BrightTalk who host the webinar and gather your registration data.
This data may then be passed to pharmaphorum media limited, and in turn passed to the company(ies) we are partnering with to bring you the webinar. This data may be used by us and them for occasional marketing purposes. It will not be shared with any further third parties.
By clicking to register for this webinar you give consent for any data you provide to be used in this way.
If at any point you no longer wish to be contacted based on the information you provide during the registration for this webinar, please send an email to email@example.com requesting that your information is deleted in accordance with the General Data Protection Regulation.